hydralazine and sq-11725

hydralazine has been researched along with sq-11725 in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19905 (45.45)18.7374
1990's0 (0.00)18.2507
2000's5 (45.45)29.6817
2010's1 (9.09)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Topliss, JG; Yoshida, F1
Lombardo, F; Obach, RS; Waters, NJ1
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Katus, H; Mall, G; Mehls, O; Rambausek, M; Ritz, E1
Freis, ED1
Akbar, S; Duchin, KL; Levin, NW; Meister, J; Michaels, RS1
Spence, JD1
Amann, K; Dikow, R; Kapitza, J; Kihm, LP; Ritz, E; Tiefenbacher, C; Törnig, J; Zeier, M1

Trials

2 trial(s) available for hydralazine and sq-11725

ArticleYear
Veterans Administration cooperative study on nadolol as monotherapy and in combination with a diuretic.
    American heart journal, 1984, Volume: 108, Issue:4 Pt 2

    Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Bendroflumethiazide; Clinical Trials as Topic; Diuretics; Double-Blind Method; Drug Therapy, Combination; Humans; Hydralazine; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Nadolol; Oxprenolol; Propanolamines; Propranolol; Random Allocation; Renin; United States; United States Department of Veterans Affairs

1984
Efficacy of nadolol alone and combined with bendroflumethiazide and hydralazine for systemic hypertension.
    The American journal of cardiology, 1983, Dec-01, Volume: 52, Issue:10

    Topics: Adult; Aged; Antihypertensive Agents; Bendroflumethiazide; Blood Pressure; Clinical Trials as Topic; Drug Therapy, Combination; Heart Rate; Humans; Hydralazine; Hypertension; Male; Middle Aged; Nadolol; Propanolamines; Random Allocation; Time Factors; United States; United States Department of Veterans Affairs

1983

Other Studies

9 other study(ies) available for hydralazine and sq-11725

ArticleYear
QSAR model for drug human oral bioavailability.
    Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13

    Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship

2000
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
    Journal of medicinal chemistry, 2008, Nov-13, Volume: 51, Issue:21

    Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship

2008
Physicochemical determinants of human renal clearance.
    Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15

    Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight

2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Myocardial hypertrophy in rats with renal insufficiency.
    Kidney international, 1985, Volume: 28, Issue:5

    Topics: Adenosine Triphosphatases; Animals; Blood Pressure; Blood Transfusion; Calcium; Cardiomegaly; Hydralazine; Isoenzymes; Kidney Diseases; Male; Metoprolol; Microscopy, Electron; Myocardium; Myosins; Nadolol; Nephrectomy; Organ Size; Parathyroid Glands; Prazosin; Propanolamines; Rats; Rats, Inbred Strains; Trifluoperazine

1985
Nadolol in hypertensive patients maintained on long-term hemodialysis.
    American heart journal, 1984, Volume: 108, Issue:4 Pt 2

    Topics: Adrenergic beta-Antagonists; Blood Pressure; Drug Therapy, Combination; Female; Furosemide; Half-Life; Heart Rate; Humans; Hydralazine; Hypertension, Renal; Kinetics; Male; Middle Aged; Nadolol; Propanolamines; Renal Dialysis; Time Factors

1984
Effects of antihypertensive agents on blood velocity: implications for atherogenesis.
    Canadian Medical Association journal, 1982, Oct-15, Volume: 127, Issue:8

    Topics: Adult; Aged; Antihypertensive Agents; Arteriosclerosis; Blood Flow Velocity; Blood Pressure; Female; Heart Rate; Humans; Hydralazine; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Nadolol; Placebos; Propanolamines; Propranolol; Ultrasonography

1982
Increased infarct size in uremic rats: reduced ischemia tolerance?
    Journal of the American Society of Nephrology : JASN, 2004, Volume: 15, Issue:6

    Topics: Animals; Body Weight; Coronary Vessels; Heart Ventricles; Hydralazine; Imidazoles; Ischemia; Male; Myocardial Infarction; Myocardial Ischemia; Myocardium; Nadolol; Necrosis; Nephrectomy; Perfusion; Rats; Rats, Sprague-Dawley; Reperfusion; Salts; Time Factors; Uremia

2004
chemdatabank.com